COVID-19 and Learning about Lung Fibrosis

Emerging understanding of the clinical course of COVID-19 may enable a better understanding of fibrosis in the lung. Future learnings may eventually be applicable to IPF and require new approaches to drug development. Reversing fibrosis and restoring lung function has been an aspiration for the treatment of patients with interstitial lung disease (ILD) but the […]